Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
2.200
-0.050 (-2.22%)
At close: Jun 27, 2025, 4:00 PM
2.229
+0.029 (1.32%)
After-hours: Jun 27, 2025, 7:54 PM EDT

Atai Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
4422232344411,223-
Upgrade
Market Cap Growth
-17.54%-4.66%-46.95%-63.92%--
Upgrade
Enterprise Value
37216446161806-
Upgrade
Last Close Price
2.331.331.412.667.63-
Upgrade
PS Ratio
205.76724.60745.461893.6860.03-
Upgrade
PB Ratio
3.061.920.961.663.17-
Upgrade
P/TBV Ratio
2.971.980.971.693.25-
Upgrade
EV/Sales Ratio
199.90532.66147.41690.7939.54-
Upgrade
Debt / Equity Ratio
0.190.230.090.070.010.02
Upgrade
Asset Turnover
0.010.000.000.000.08-
Upgrade
Quick Ratio
3.502.559.0014.0117.567.99
Upgrade
Current Ratio
4.073.219.2214.4317.928.10
Upgrade
Return on Equity (ROE)
-79.43%-83.16%-17.21%-48.31%-72.40%-230.26%
Upgrade
Return on Assets (ROA)
-26.04%-27.54%-25.52%-25.09%-28.61%-66.32%
Upgrade
Return on Capital (ROIC)
-28.31%-30.48%-27.83%-26.84%-30.91%-73.14%
Upgrade
Earnings Yield
-33.73%-66.88%-17.18%-34.54%-13.72%-
Upgrade
FCF Yield
-17.83%-36.94%-36.05%-23.85%-5.27%-
Upgrade
Buyback Yield / Dilution
-3.07%-0.83%-2.00%-12.62%-48.64%-973.40%
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q